Prevention & Control Clinical Trial
Official title:
Cohort Study of Risk Reducing Salpingectomy (RRS) Versus Standard Tubal Sterilization Among Women Who Desire Sterilization
Women undergoing surgical sterilization will be interested in risk reducing salpingectomy, and surgeons performing the procedure will be able to successfully complete the salpingectomy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04062578 -
Effects Provided by a Physiotherapy Treatment Preventing Lower Extremity Injuries in Female Football Players
|
N/A | |
Not yet recruiting |
NCT04400019 -
Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
|
Phase 2/Phase 3 | |
Completed |
NCT00793455 -
Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders
|
N/A | |
Completed |
NCT00563264 -
KAN-DO: A Family-based Intervention to Prevent Childhood Obesity
|
N/A | |
Completed |
NCT05261152 -
S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
|
Phase 4 | |
Recruiting |
NCT06164600 -
Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
|
Phase 2 | |
Completed |
NCT05365737 -
Substantivity of Oral Rinses: Comparative Study
|
N/A | |
Completed |
NCT01776424 -
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
|
Phase 3 | |
Enrolling by invitation |
NCT02580279 -
Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
|
Phase 2 | |
Recruiting |
NCT01747278 -
Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT02577393 -
Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy
|
Phase 2 | |
Withdrawn |
NCT01137591 -
Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
|
N/A |